PharmaEssentia is looking to expand the reach of its FDA-approved rare blood cancer treatment Besremi to another rare blood ...

Interferon gamma-1b is under clinical development by Amgen and currently in Phase II for Relapsed Acute Myeloid Leukemia.

When interferon treatment was being developed in the Soviet Union, this was effectively overlooked in the West during the cold-war era due to its concentration on the development of vaccines.

Learn about Arbutus's promising Hepatitis B treatments, strong financial position, and projections for the global market.

There are three different types of thyroid dysfunction associated with IFN treatment: (1) autoimmune (often subclinical) hypothyroidism; (2) destructive thyroiditis; and (3) Graves' hyperthyroidism.

PharmaEssentia (TWSE: 6446), a global biopharmaceutical company, reaffirms its enduring commitment to creating robust and reliable access to critical interferon therapies. Amidst growing global ...

Measuring levels of key proteins in patients' saliva may be a relatively easy way for dentists and even patients themselves to track the progression of gum disease (periodontitis), suggests a new ...

Both dose levels of modakafusp alfa “resulted in good response rates with similar safety profiles,” according to researchers.